Serina Therapeutics Inc (SER)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | -14 | 14 | 51 | 5 | 3,087 |
| Gross Profit | -14 | 14 | 51 | 5 | 3,087 |
| Operating Expenses | 5,535 | 5,326 | 3,917 | 2,326 | 2,846 |
| Operating Income | -5,549 | -5,312 | -3,866 | -2,321 | 241 |
| Interest Expense | 17 | 16 | 307 | 186 | 264 |
| Other Income | 2,814 | 6,711 | 9,350 | -12,508 | 1,074 |
| Pre-tax Income | -2,752 | 1,383 | 5,177 | -15,015 | 1,051 |
| Net Income Continuous | -2,752 | 1,383 | 5,177 | -15,015 | 1,051 |
| Minority Interests | -12 | -27 | -27 | N/A | N/A |
| Net Income | $-2,740 | $1,410 | $5,204 | $-15,015 | $1,051 |
| EPS Basic Total Ops | 3.10 | 0.16 | 0.61 | -5.38 | 0.42 |
| EPS Basic Continuous Ops | 3.09 | 0.16 | 0.61 | -5.38 | 0.42 |
| EPS Diluted Total Ops | 3.23 | 0.13 | 0.51 | -5.38 | 0.19 |
| EPS Diluted Continuous Ops | 3.22 | 0.13 | 0.51 | -5.38 | 0.18 |
| EPS Diluted Before Non-Recurring Items | -0.27 | 0.13 | 0.51 | -3.38 | N/A |
| EBITDA(a) | $-5,485 | $-5,248 | $-3,502 | $-2,274 | $247 |